Excretion into bile and gallbladder tissue level of a new quinolone, NM441, and its clinical efficacy on surgical infections

Japanese Journal of Chemotherapy

Volumn 44, Issue SUPPL. 1, 1996, Pages 462-470

  Murakami, K ^a   Tanimura, H ^a   Ishimoto, K ^a   Uchiyama, K ^a   Iwakura, S ^a   Aoki, Y ^a   Oka, S ^a   Donishi, H ^a   Yamamoto, S ^a   Ichimiya, G ^a   Kobayashi, Y ^a   Iwahashi, H ^a   Mishima, H ^a   Fukunaga, H ^a   Hayashido, M ^a   Hotta, T ^a   Hashimoto, M ^a   Sakamoto, Y ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

NM394; NM441

Indexed keywords

6 FLUORO 1 METHYL 4 OXO 7 (1 PIPERAZINYL) 4H 1,3 THIAZETO[3,2 A]QUINOLINE 3 CARBOXYLIC ACID; CIPROFLOXACIN; GLUCURONIDE; OFLOXACIN; PRULIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOSUFLOXACIN; URSODEOXYCHOLIC ACID;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ARTICLE; CHOLANGITIS; CHOLECYSTITIS; CLINICAL ARTICLE; COMMON BILE DUCT; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG EXCRETION; DRUG GLUCURONIDATION; DRUG TISSUE LEVEL; FEMALE; GALLBLADDER; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PORTAL VEIN; SURGICAL INFECTION;

EID: 0029997365     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)